These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19823066)

  • 1. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
    Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
    Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
    Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
    Hesterberg PE; Banerji A; Oren E; Penson RT; Krasner CN; Seiden MV; Wong JT
    J Allergy Clin Immunol; 2009 Jun; 123(6):1262-7.e1. PubMed ID: 19501233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protocol for risk stratification of patients with carboplatin-induced hypersensitivity reactions.
    Patil SU; Long AA; Ling M; Wilson MT; Hesterberg P; Wong JT; Banerji A
    J Allergy Clin Immunol; 2012 Feb; 129(2):443-7. PubMed ID: 22099941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
    Wang AL; Patil SU; Long AA; Banerji A
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
    Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
    J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Testing in the Evaluation and Management of Carboplatin-Related Hypersensitivity Reactions.
    Lax T; Long A; Banerji A
    J Allergy Clin Immunol Pract; 2015; 3(6):856-62. PubMed ID: 26432514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
    Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S
    Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.
    Robinson JB; Singh D; Bodurka-Bevers DC; Wharton JT; Gershenson DM; Wolf JK
    Gynecol Oncol; 2001 Sep; 82(3):550-8. PubMed ID: 11520154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2004 Nov; 95(2):370-6. PubMed ID: 15491759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization in patients with hypersensitivity to platinum and taxane in gynecological cancers.
    Zwimpfer TA; Scherer K; Schötzau A; Heinzelmann-Schwarz V; Hartmann K; Vetter M; Montavon C
    Cancer Med; 2024 Jan; 13(1):e6840. PubMed ID: 38140783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin hypersensitivity: evaluation and successful desensitization protocol.
    Bruchim I; Goldberg A; Fishman A; Confino-Cohen R
    Immunotherapy; 2014; 6(8):905-12. PubMed ID: 25313569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P
    Anticancer Res; 2014 Jan; 34(1):537-40. PubMed ID: 24403513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
    Otani IM; Wong J; Banerji A
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
    Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
    Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses.
    Lee CW; Matulonis UA; Castells MC
    Gynecol Oncol; 2005 Nov; 99(2):393-9. PubMed ID: 16054201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.
    Altwerger G; Florsheim EB; Menderes G; Black J; Schwab C; Gressel GM; Nelson WK; Carusillo N; Passante T; Huang G; Litkouhi B; Azodi M; Silasi DA; Santin A; Schwartz PE; Ratner ES
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2449-2456. PubMed ID: 30255380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.